News

Home>News
News2020-07-17T11:41:26-04:00
May 42021

Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease

May 4th, 2021|Categories: Featured, Investor News, News|Tags: , , , , , |

Jackson Center, PA, May 4, 2021 – Halberd Corporation (OTC-PINK: "HALB") announces the appointment of Dr. Mitchell S. Felder, previously a consultant to Halberd Corporation, to the position of Chief Technical Officer.  Dr. Patricio Reyes, former Chief Technical Officer, has requested reduced duties due to pressing other outside commitments, but will continue to serve as a valuable contributor to the company moving forward, as a consultant. Dr. Felder is a Board-Certified Neurologist and is the ...

Apr 262021

Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser

April 26th, 2021|Categories: Featured, Investor News, News|Tags: , , , , , , |

Jackson Center, PA, April 26, 2021 – Halberd Corporation (OTC-PINK: "HALB") filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, “Treating and Curing Covid-19 Infection Utilizing a Laser.”  The Patent Cooperation Treaty has over 150 participating countries and allows an inventor to seek patent protection in numerous countries simultaneously. William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, “We continue to protect our technology in many countries across ...

Apr 192021

Halberd Corporation Moves Radio Frequency (RF) Disease Elimination Effort Forward With the Addition of Youngstown State University (YSU) and Dr. William G. Sturrus

April 19th, 2021|Categories: Featured, Investor News, News, Uncategorized|Tags: , , , , , , , |

Brings Critical Radio Frequency Wave Expertise to Company’s Effort Jackson Center, PA, April 19, 2021 – Halberd Corporation (OTC-PINK: "HALB") is pleased to announce Youngstown State University’s (YSU) Dr. William G. Sturrus will lead the Radio Frequency (RF) research on Halberd’s Disease Elimination multi-organization Task Force.  Dr. Sturrus, who has 30 years of radio frequency experience in the atomic physics area, is currently the Chairman of the Physics, Astronomy, Geology, and Environmental Sciences Department ...

Apr 122021

Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment

April 12th, 2021|Categories: Featured, Investor News, News, Uncategorized|Tags: , , , , , , , |

Jackson Center, PA, April 12, 2021 – Halberd Corporation (OTC-PINK: "HALB") filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, “Covid-19 Inflammatory Cytokine Storm Treatment.”  The Patent Cooperation Treaty has over 150 participating countries and allows an inventor to seek patent protection in numerous countries simultaneously. William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, “We sought patent protection beyond the U.S. through the PCT process, thus we ...

Apr 62021

Halberd Corporation CEO Letter

April 6th, 2021|Categories: Featured, Investor News, News|Tags: , , , |

Q1-21 Accomplishments and Q2 Plans Jackson Center, PA, April 6, 2021 Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC-PINK: HALB) It has been a very busy and fruitful first quarter of 2021.  Often, people get so wrapped up in the day-to-day events that we lose sight of just how far we have traveled.  So, it is worthwhile to stop every so often and measure our progress. STOCK PERFORMANCE One year ago, Halberd re-invented ...

Mar 302021

Halberd Corporation’s Scientific Breakthrough: Conjugating Metallic Particles to SARS-CoV-2 and E. Coli Antigens

March 30th, 2021|Categories: Featured, Investor News, News, Uncategorized|Tags: , , , , , |

Paves Way for Disease Elimination by Radio Frequency Waves Jackson Center, PA, March 30, 2021 – Halberd Corporation (OTC-PINK: "HALB") has successfully conjugated (joined) metallic nanoparticles with its patent-pending SARS-CoV-2 antibody, while still maintaining the antibody’s antigen-neutralizing properties.  This was a key scientific hurdle to overcome in implementing its patent-pending extracorporeal disease eradication methodology through the use of radio frequency (RF) energy. The moieties (nanoparticles conjugated with an antibody and antigen) resonate (vibrate) at their ...

Go to Top